Philanthropy + Public Service
AMGA Foundation and our member groups have accelerated health outcomes for millions of
patients with chronic and prevent-
able diseases. Our collaborative
model closes the gap between the
identification and implementation
of best practices benefiting patients
with cardiovascular disease, diabe-
tes, obesity, and more.
Already, we’ve reached 26 million
patients. With your support, we can
continue this vital work, building
upon proven successes to expand
our programs to even more medical
Closing the Gap
Help AMGA Foundation reach more Americans living with
groups, address the complexities of
chronic and preventable diseases
from fresh angles, and create a
healthier America for 100 million
patients by 2025.
Will you help us get there? Donate
today at amga.org/donate.
On March 28, at the Chronic Care Roundtable (CCR) meeting,
AMGA Foundation convened leaders from nine corporations and
more than five AMGA member groups to discuss the spectrum
of vascular complications associated with Type 2 diabetes,
including cardiovascular disease, congestive heart failure,
peripheral artery disease, coronary artery disease, and stroke.
In breakout discussions following the panel, attendees
discussed new recommendations and sought solutions for
overcoming clinical inertia in the treatment of Type 2 diabetes
and vascular risk with GLP- 1 analogues, SGLT- 2 inhibitors, or
Our next CCR meeting is scheduled for November 13, 2019.
Corporations interested in joining the CCR should contact
Christina Santos at firstname.lastname@example.org or 703.838.0033
Novel Treatment Options for Patients with Type 2 Diabetes with Vascular Risk